✦ LIBER ✦

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial

✍ Scribed by Winston W. Tan; Jacob B. Allred; Muhammad Salim; Patrick Flynn; Paul A.S. Fishkin; Philip J. Stella; Martin Wiesenfeld; Albert M. Bernath; Tom R. Fitch; Edith A. Perez

Book ID: 113538962
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 354 KB
Volume: 12
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2012.01.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

194 A Phase II Study of Trastuzumab Plus

194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)

✍ A. Urruticoechea; P. Canney; R. Separovic; T. Bachelot; J. Efran; J.L. Canon; P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

2124 POSTER Triple combination of oral v

2124 POSTER Triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer (MBC): latest results of an international phase II trial

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; O. Perrot; G. Villano 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A Phase II trial of the combination of v

A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines

✍ George Orphanos; Athanasios Alexopoulos; Savvoula Malliou; George Ioannidis; Ale 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

446 PUBLICATION A phase II trial of tras

446 PUBLICATION A phase II trial of trastuzumab (H) plus capecitabine (X) as first-line treatment in patients (pts) with HER-2-positive metastatic breast cancer (MBC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

All-oral combination of oral vinorelbine

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

✍ Tubiana-Mathieu, N; Bougnoux, P; Becquart, D; Chan, A; Conte, P-F; Majois, F; Es 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB